Literature DB >> 26387621

Continuous twin-screw granulation for enhancing the dissolution of poorly water soluble drug.

Mohammed Maniruzzaman1, Arun Nair2, Maxcene Renault3, Uttom Nandi4, Nicholaos Scoutaris4, Richard Farnish5, Michael S A Bradley5, Martin J Snowden4, Dennis Douroumis6.   

Abstract

The article describes the application of a twin-screw granulation process to enhance the dissolution rate of the poorly water soluble drug, ibuprofen (IBU). A quality-by-design (QbD) approach was used to manufacture IBU loaded granules via hot-melt extrusion (HME) processing. For the purpose of the study, a design of experiment (DoE) was implemented to assess the effect of the formulation compositions and the processing parameters. This novel approach allowed the use of, polymer/inorganic excipients such as hydroxypropyl methylcellulose (HPMC) and magnesium aluminometasilicate (Neusilin(®)-MAS) with polyethylene glycol 2000 (PEG) as the binder without requiring a further drying step. IBU loaded batches were processed using a twin screw extruder to investigate the effect of MAS/polymer ratio, PEG amount (binder) and liquid to solid (L/S) ratios on the dissolution rates, mean particle size and the loss on drying (LoD) of the extruded granules. The DoE analysis showed that the defined independent variables of the twin screw granulation process have a complex effect on the measured outcomes. The solid state analysis showed the existence of partially amorphous IBU state which had a significant effect on the dissolution enhancement in acidic media. Furthermore, the analysis obtained from the surface mapping by Raman proved the homogenous distribution of the IBU in the extruded granulation formulations.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DVS; Dissolutions; DoE; Granulations; QbD; Raman; Twin screw

Mesh:

Substances:

Year:  2015        PMID: 26387621     DOI: 10.1016/j.ijpharm.2015.09.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Study the influence of formulation process parameters on solubility and dissolution enhancement of efavirenz solid solutions prepared by hot-melt extrusion: a QbD methodology.

Authors:  Jaywant Pawar; Dilipkumar Suryawanshi; Kailas Moravkar; Rahul Aware; Vasant Shetty; Mohammed Maniruzzaman; Purnima Amin
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

Review 2.  An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part II.

Authors:  Sandeep Sarabu; Suresh Bandari; Venkata Raman Kallakunta; Roshan Tiwari; Hemlata Patil; Michael A Repka
Journal:  Expert Opin Drug Deliv       Date:  2019-05-14       Impact factor: 6.648

Review 3.  Continuous twin screw granulation - An advanced alternative granulation technology for use in the pharmaceutical industry.

Authors:  Suresh Bandari; Dinesh Nyavanandi; Venkata Raman Kallakunta; Kartik Yadav Janga; Sandeep Sarabu; Arun Butreddy; Michael A Repka
Journal:  Int J Pharm       Date:  2020-03-16       Impact factor: 5.875

Review 4.  Melt extrusion with poorly soluble drugs - An integrated review.

Authors:  Michael A Repka; Suresh Bandari; Venkata Raman Kallakunta; Anh Q Vo; Haley McFall; Manjeet B Pimparade; Ajinkya M Bhagurkar
Journal:  Int J Pharm       Date:  2017-11-02       Impact factor: 5.875

Review 5.  Advances in Twin-Screw Granulation Processing.

Authors:  Uttom Nandi; Vivek Trivedi; Steven A Ross; Dennis Douroumis
Journal:  Pharmaceutics       Date:  2021-04-27       Impact factor: 6.321

Review 6.  The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.

Authors:  Khadijah Edueng; Denny Mahlin; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-05-18       Impact factor: 4.200

7.  Chemico-calorimetric analysis of amorphous granules manufactured via continuous granulation process.

Authors:  Mridul Majumder; Saeid Rajabnezhad; Ali Nokhodchi; Mohammed Maniruzzaman
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.